Former Secretary of State Mike Pompeo supports Nippon Steel’s $14.9 billion bid for U.S. Steel, viewing it as vital for countering China. However, President Biden is likely to block the deal due to national security concerns. The acquisition’s fate remains uncertain, impacting U.S. Steel’s stock and the global steel market.
Donald Trump, the US President-elect, has announced he will not be inviting former Ambassador Nikki Haley and former Secretary of State Mike Pompeo to join his upcoming administration. This decision comes after a history of complex relations between Trump and both individuals, marked by both collaboration and conflict. While both Haley and Pompeo served in Trump’s first administration, they later became critical of his leadership and policies, particularly in the context of the 2024 presidential election.
Former UN Ambassador Nikki Haley and ex-Secretary of State Mike Pompeo, key figures in Donald Trump’s previous administration, have been excluded from his new team, signifying a possible change in his governance and foreign policy approach. This move also raises questions about the future political dynamics within the Republican Party.
Former Secretary of State Mike Pompeo criticizes President Biden’s prescription drug price plan, arguing it will only benefit the government and Big Pharma while raising costs for families. He specifically targets the Federal Trade Commission’s (FTC) proposed regulations on pharmacy benefit managers (PBMs), arguing they will harm patients by increasing drug prices and weakening the free market.
